Side Effects of tepotinib: A Synthesis of Findings from 4 Studies
- Home
- Side Effects of tepotinib
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of tepotinib: A Synthesis of Findings from 4 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major findings
Tepotinib is a potent inhibitor of c-Met, which has been approved for use in Japan for the treatment of patients with non-small cell lung cancer (NSCLC) harboring an MET exon 14 skipping alteration who have progressed after platinum-based therapy. 4 To identify the generation of iminium intermediates in its metabolism, practical and in silico approaches were used to screen for the metabolic profile and reactive intermediates of tepotinib. 4 Understanding the bioactive center and structural alerts in the tepotinib structure has helped in making targeted modifications to improve its safety. 4
Reason for side effects
The generation of iminium intermediates in the metabolic pathway of tepotinib may provide an explanation for its adverse reactions. 4 As proposed by the DEREK software and a Xenosite reactivity model, the piperidine ring is considered a structural alert for toxicity, which was confirmed by practical experiments. 4 Steric hindrance or isosteric replacement at the α-carbon of the piperidine ring stops the bioactivation sequence, which was confirmed using the DEREK software. 4
Common side effects
Hepatotoxicity
Use of the antithyroid drugs (ATDs) thiamazole (MMI) and propylthiouracil (PTU) is associated with a high frequency of side effects. 1 When patients experience side effects with one (the 1st) ATD, it is usually discontinued and another is administered (the 2nd ATD). 1 We investigated side effects associated with the 1st and 2nd ATDs, and found hepatotoxicity to be one of them. 1 .
Cutaneous reactions
Use of the antithyroid drugs (ATDs) thiamazole (MMI) and propylthiouracil (PTU) is associated with a high frequency of side effects. 1 When patients experience side effects with one (the 1st) ATD, it is usually discontinued and another is administered (the 2nd ATD). 1 We investigated side effects associated with the 1st and 2nd ATDs, and found cutaneous reactions to be one of them. 1 .
Side effects countermeasures
Countermeasures for Hepatotoxicity
Hepatotoxicity is a common side effect associated with the use of antithyroid drugs (ATDs). 1 Many of the side effects of ATDs are known to be dose-dependent. 1 Therefore, it is important to reduce the dose of ATDs to prevent side effects such as hepatotoxicity. 1 It is also important to monitor liver function by performing regular blood tests. 1
Countermeasures for Cutaneous reactions
Cutaneous reactions are a common side effect associated with the use of antithyroid drugs (ATDs). 1 Many of the side effects of ATDs are known to be dose-dependent. 1 Therefore, it is important to reduce the dose of ATDs to prevent side effects such as cutaneous reactions. 1 Also, if cutaneous reactions occur, treatments such as steroid cream may be effective. 1
Comparison between studies
Common points of the studies
All these studies are investigating the side effects associated with the use of specific drugs. 4 1 Also, all these studies are looking for ways to reduce the side effects of drugs. 4 1
Differences between the studies
These studies vary in the drugs they are investigating. 4 1 Also, the research methods used in the studies differ. 4 1
Points to note for application to real life
The findings of these studies can be helpful for the treatment of patients using tepotinib or antithyroid drugs. 4 1 However, these studies do not apply to everyone. 4 1 Therefore, it is important for patients receiving treatment to discuss with their doctors and determine the appropriate course of treatment. 4 1
Limitations of current research
These studies do not apply to everyone. 4 1 Therefore, the findings of these studies cannot be applied to everyone. 4 1 These studies are also focused on specific drugs. 4 1 Therefore, we cannot learn about the side effects of other drugs from these studies. 4 1
Future directions for research
The information obtained from these studies could help in the development of safer and more effective treatments. 4 1 Therefore, it is necessary to further investigate the side effects of these drugs. 4 1 It is also necessary to investigate the side effects of other drugs. 4 1 Furthermore, new methods need to be developed to reduce the side effects of drugs. 4 1
Conclusion
Tepotinib and antithyroid drugs are effective drugs for the treatment of certain cancers and thyroid diseases. 4 1 However, these drugs can cause side effects such as hepatotoxicity and cutaneous reactions. 4 1 Therefore, it is important to discuss with your doctor and determine the appropriate course of treatment when using these drugs. 4 1 Also, new methods need to be developed to reduce the side effects of these drugs. 4 1
Article Type
Author: OtsukaFumiko, NohJaeduk Y, ChinoToshiko, ShimizuTaeko, MukasaKoji, ItoKunihiko, ItoKoichi, TaniyamaMatsuo
Language : English
Author: MarinaDjordje, RasmussenÅse Krogh, Buch-LarsenKristian, GillbergLinn, AnderssonMichael, SchwarzPeter
Language : English
Author: JavidiNajmeh, KhorasaniZahra Mazloum, SalariRoshanak, NiroumandShabnam, YousefiMahdi
Language : English
Author: AbdelhameedAli S, AttwaMohamed W, KadiAdnan A
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.